Author:
Chatelut Etienne,Chevreau Christine,Blancy Evelyne,Lequellec Anne,Canal Pierre,Roche Henri,Houin Georges,Bugat Roland
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference26 articles.
1. Aisner J, Echo DA van, Whitacre M, Wiernik P (1982) A phase I trial of continuous infusion VP16-213 (etoposide). Cancer Chemother Pharmacol 7: 157
2. Arbuck SG, Douglass HO, Crom WR, Goodwin P, Silk Y, Cooper C, Evans WE (1986) Etoposide pharmacokinetics in patients with normal and abnormal organ origin. J Clin Oncol 4: 1690
3. Batist G, Carney DN, Cowan KH, Veah SR, Gilliom M, Bunn PA, Ihde DC (1986) Etoposide (VP16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates. J Clin Oncol 4: 982
4. Bennett CL, Sinkule JA, Schilsky RL, Senekjian E, Choi KE (1987) Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. Cancer Res 47: 1952
5. Brindley CJ, Antoniw P, Newlands ES, Bagshawe KD (1985) Pharmacokinetics and toxicity of the epipodophyllotoxin derivative (VP16-213) in patients with gestational choriocarcinoma and malignant teratoma. Cancer Chemother Pharmacol 15: 66
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献